Cystic Fibrosis: Detecting Changes in Airway Inflammation with FDG PET/CT

Authors:

Abstract
Fluorine 18 fluorodeoxyglucose PET/CT imaging can help quantify and localize pulmonary inflammation in cystic fibrosis (CF) and track clinical improvement in pediatric patients with CF who are admitted to the hospital with pulmonary exacerbations before and after intravenous antibiotic therapy. PurposeTo determine if fluorine 18 fluorodeoxyglucose (FDG) positron emission tomographic (PET)/computed tomographic (CT) imaging can depict a treatment effect from intravenous antibiotics for pulmonary exacerbation in cystic fibrosis (CF).Materials and MethodsThe study was approved by the institutional review board of the Hospital for Sick Children and by Health Canada. Consent was obtained from all subjects. Patients with CF who were between 6 and 18 years of age and were admitted for a pulmonary exacerbation were eligible for the study. FDG PET/CT examinations (with low-dose CT) were performed on days 1 and 14 of admission (±72 hours). PET activity was quantified by using standardized uptake values (SUVs) through assessment of background activity (mean SUV [SUVmean]) and superimposed focal uptake (maximum SUV [SUVmax]) for each lung zone. CT studies were scored by using the CF-CT model. SUVs from pre- and posttherapy studies were compared by using paired t tests. Unpaired t tests were used to compare d...

This publication has 41 references indexed in Scilit: